Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron that just showed positive results from a Phase 2 trial.

For Abbotsford, the median birth year was identical in both years (2001), while the average sits slightly older in the 25-26 ...

Auston Matthews, the NHL’s leading goal scorer since he entered the league in 2016, isn’t scoring anymore. Thirty-five games ...

A single-dose CRISPR-CasRx nanotherapy targeting a host enzyme reduces SARS-CoV-2 viral load and promotes alveolar repair in a hamster model of long COVID, offering a promising strategy for treating ...

Omar García Harfuch is overseeing one of the most aggressive offensives in years against Mexico’s powerful criminal groups.

Donald Trump's administration is turning immigration screening into the backbone of a DNA surveillance system that reaches ...

The New Jersey Devils might have had a rough start to December, but it appears that the team is back on an even keel. After ...

Instead of chasing superstars, the Wild masterfully contained McDavid through strategic matchups, proving restraint truly ...

At the heart of it, on a goalscoring run to remember, is Joshua Abbott, who has been living it up simultaneously on one of ...

David Raya has been described as the most attacking goalkeeper in the league by Arsenal boss Mikel Arteta. BBC Sport analyse ...

From mudstones on Mars to strange gases in exoplanet atmospheres, tentative evidence for extraterrestrial life is starting to ...

The U.S. childhood immunization schedule, the grid of colored bars pediatricians share with parents, recommends a set of vaccines given from birth through adolescence to prevent a range of serious ...